Cure8 research brief
This study suggests vonoprazan — a potassium-competitive acid blocker usually used for acid-related disorders — showed protective effects in a mouse model of ulcerative colitis through antioxidant, anti-inflammatory, and mitochondrial-preserving actions.
If replicated and translated, it could point to new mechanisms or drug-repurposing opportunities relevant to IBD research.
Researchers studying IBD mechanisms or drug repurposing, translational scientists interested in mitochondrial and oxidative-stress pathways, and clinicians curious about emerging preclinical work on non-traditional IBD drug targets.
This is an abstract-summary of a preclinical (mouse) study testing vonoprazan in a DSS colitis model.
The paper reports that oral vonoprazan (10 or 20 mg/kg/day) reduced disease activity index, systemic CRP, and histologic injury; increased antioxidant markers and tight-junction proteins; lowered pro-inflammatory cytokines and immune-cell markers; and improved mitochondrial energy measurements in colonic tissue.
These findings come from an experimental animal model rather than human patients.
This is an animal (DSS-induced colitis in mice) study reported in a journal abstract; results do not establish safety or effectiveness in humans. Preclinical positive findings often do not translate to clinical benefit, and dosing/biologic effects can differ between species. Further studies, including controlled human trials, would be needed before any clinical implications.
Review the original publication for the complete reporting, methods, and context.
Conflict statement: Declaration of Competing Interest ☒ The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
This study suggests the cancer drug lapatinib reduced colon damage and liver changes in a rat model of chemical colitis, which could point to new research directions for IBD treatments or gut–liver injury mechanisms.
This animal study suggests date palm pollen extract reduced inflammation and tissue damage in a rat model of colitis, which could point to new lines of research into dietary supplements or natural compounds for gut...
This study identifies a plant-derived polysaccharide (from the stem of Dendrobium huoshanense) that reduced inflammation and tissue injury in a mouse model of ulcerative colitis and points to GLP-1 signaling as a likely...
